Andrew Luster

Lung-Resident Memory Th2 Cells in Asthma: New Therapeutic Targets

National Institute of Allergy and Infectious Diseases · R01

Contact PI · $748K · Massachusetts General Hospital

Center for Studies of Inflammatory Bowel Disease (CSIBD)

National Institute of Diabetes and Digestive and Kidney Diseases · P30

Project lead · $1.6M · Massachusetts General Hospital

Research Training in Rheumatology at Massachusetts General Hospital

National Institute of Arthritis and Musculoskeletal and Skin Diseases · T32

Contact PI · $6.6M · Massachusetts General Hospital

Research Training in Pulmonary Immunology and Allergy at Massachusetts General Hospital

National Heart, Lung, and Blood Institute · T32

Contact PI · $8.6M · Massachusetts General Hospital

Lung-Resident Memory Th2 Cells in Asthma

Principal investigator · Active not recruiting

Andrew D. Luster, M.D.,Ph.D.

Induced Tolerogenic Dendritic Cells as Modulators of Allergic Asthma

Principal investigator · Completed · Phase 1

Andrew D. Luster, M.D.,Ph.D.

T Cell Effector and Regulatory Mechanisms in Asthma

Principal investigator · Completed · Phase 1

Andrew D. Luster, M.D.,Ph.D.

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

Sub-investigator · Recruiting · Phase 1

Benjamin Medoff